Reversal of the activity-dependent suppression of GABA-mediated inhibition in hippocampal slices from γ-vinyl GABA (vigabatrin)-pretreated rats

Neuropharmacology

Volumn 39, Issue 1, 2000, Pages 65-74

  Jackson, Michael F ^a   Esplin, Barbara ^a   Čapek, Radan ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Anticonvulsant; GABA; Inhibition; IPSPs; Paired pulse; Vigabatrin

Indexed keywords

4 (3 PHOSPHONOPROPYL) 2 PIPERAZINECARBOXYLIC ACID; 4 AMINOBUTYRIC ACID; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; AUTORECEPTOR; BACLOFEN; VIGABATRIN;

4 AMINOBUTYRIC ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DRUG EFFECT; GABAERGIC TRANSMISSION; HIPPOCAMPUS; INHIBITORY POSTSYNAPTIC POTENTIAL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTIC INHIBITION;

6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ANIMALS; ANTICONVULSANTS; ELECTRIC STIMULATION; EVOKED POTENTIALS; GAMMA-AMINOBUTYRIC ACID; HIPPOCAMPUS; INTERNEURONS; MALE; PIPERAZINES; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; SYNAPSES; SYNAPTIC TRANSMISSION; VIGABATRIN;

EID: 0033991226     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00075-1     Document Type: Article

References (41)

1. Abdul-Ghani A.S., Norris P.J., Smith C.C.T., Bradford H.F. Effects of γ-acetylenic GABA and γ-vinyl GABA on synaptosomal release and uptake of GABA. Biochem. Pharmacol. 30:1981;1203-1209.
2. Abe M., Matsuda M. On the existence of two GABA pools associated with newly synthesized GABA and with newly taken up GABA in nerve terminals. Neurochem. Res. 8:1983;563-573.
3. Arzimanoglou A.A., Dumas C., Ghirardi L. Multicentre clinical evaluation of vigabatrin (Sabril) in mild to moderate partial epilepsies. French Neurologists Sabril Study Group. Seizure. 6:1997;225-231.
4. Attwell D., Barbour B., Szatkowski M. Nonvesicular release of neurotransmitter. Neuron. 11:1993;401-407.
5. Ben-Menachem E. Pharmacokinetic effects of vigabatrin on cerebrospinal fluid amino acids in humans. Epilepsia. 30(S3):1989;S12-S14.
6. Bernath S. Calcium-independent release of amino acid neurotransmitters: fact or artifact. Prog. Neurobiol. 38:1992;57-91.
7. Borden L.A. GABA transporter heterogeneity: pharmacology and cellular localization. Neurochem. Int. 29:1996;335-356.
8. Brodie M.J., Dichter M.A. Drug therapy - antiepileptic drugs. New Engl. J. Med. 334:1996;168-175.
9. Čapek R., Esplin B. Frequency-dependent enhancement of hippocampal inhibition by GABA uptake blockers. Epilepsy Res. 16:1993;123-130.
10. Čapek R., Jackson M.F., Esplin B. Suppression of activity-dependent disinhibition by vigabatrin in the hippocampal slice preparation. Naunyn-Schmiedeberg's Arch. Pharmacol. 358:1998;R57 (Abstract).
11. Colbert C.M., Levy W.B. Electrophysiological and pharmacological characterization of perforant path synapses in CA1: mediation by glutamate receptors. J. Neurophysiol. 68:1992;1-8.
12. B autoreceptors in rat hippocampus. J. Physiol. Lond. 472:1993;245-265.
13. Dichter M.A., Ayala G.F. Cellular mechanisms of epilepsy: a status report. Science. 237:1987;157-164.
14. Esplin B., Čapek R., 1990. Frequency-dependent changes in efficacy of the hippocampal recurrent inhibition. Soc. Neurosci. Abstr. 16, 60, Abstr. #31.8.
15. French J.A., Mosier M., Walker S., Sommerville K., Sussman N., Barry E., Bell W., Bergen D., Browne T., III, Ferrendelli J., Fisher R., Fromm G., Homan R., Krauss G., Lai C.W., Leppik I., Leroy R., Pellock J., Penovich P., Ramsay R.E., Shinnar S., 1996. A double-blind, placebo-controlled study of vigabatrin 3 g/day in patients with uncontrolled complex partial seizures. Neurology 46, 54-61.
16. 0 on the release of neurotransmitters from cortical synaptosomes: efflux or secretion? J. Neurochem. 30:1978;1113-1125.
17. Jackson M.F., Esplin B., Čapek R., 1993. Gamma-vinyl GABA (GVG) reverses activity-dependent disinhibition in the rat hippocampus in vitro. Soc. Neurosci. Abstr. 19, 1632, Abstr. #668.14.
18. Jackson M.F., Dennis T., Esplin B., Čapek R. Acute effects of gamma-vinyl GABA (vigabatrin) on hippocampal GABAergic inhibition in vitro. Brain Res. 651:1994;85-91.
19. Jolkkonen J., Mazurkiewicz M., Lahtinen H., Riekkinen P. Acute effects of γ-vinyl GABA on the GABAergic system in rats as studied by microdialysis. Eur. J. Pharmacol. 229:1992;269-272.
20. Jung M.J., Lippert B., Metcalf B.W., Böhlen P., Schechter P.J. γ-Vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: effects on brain GABA metabolism in mice. J. Neurochem. 29:1977;797-802.
21. Löscher W. Effect of inhibitors of GABA transaminase on the synthesis, binding, uptake, and metabolism of GABA. J. Neurochem. 34:1980;1603-1608.
22. Löscher W., Jäckel R., Müller F. Anticonvulsant and proconvulsant effects of inhibitors of GABA degradation in the amygdala-kindling model. Eur. J. Pharmacol. 163:1989;1-14.
23. B receptor sensitivity in rat brain and spinal cord. NeuroReport. 6:1995;399-403.
24. B-receptor-mediated processes in region CA1 in a chronic model of temporal lobe epilepsy. J. Neurophysiol. 76:1996;1282-1296.
25. McCarren M., Alger B.E. Use-dependent depression of IPSPs in rat hippocampal pyramidal cells in vitro. J. Neurophysiol. 53:1985;557-571.
26. Michelucci R., Tassinari C.A. Response to vigabatrin in relation to seizure type. Br. J. Clin. Pharmacol. 27(S1):1989;119S-124S.
27. Nathan T., Lambert J.D.C. Depression of the fast IPSP underlies paired-pulse facilitation in area CA1 of the rat hippocampus. J. Neurophysiol. 66:1991;1704-1715.
28. Nelson M.T., Blaustein M.P. GABA efflux from synaptosomes: effects of membrane potential, and external GABA and cations. J. Membr. Biol. 69:1982;213-223.
29. Qume M., Fowler L.J. Effects of chronic oral treatment with GABA-transaminase inhibitors on the GABA system in brain, liver, kidney, and plasma of the rat. Biochem. Pharmacol. 52:1996;1355-1363.
30. Rak I.W., Lothman E.W., 1988. Electrophysiologic effects of acute and chronic gamma-vinyl-GABA on GABA-mediated inhibition in the rat hippocampus. Neurology 38 (Suppl. 1), 240, Abstr. #PP371-240.
31. Richens A. Potential antiepileptic drugs. Vigabatrin. Levy R., Mattson R., Meldrum B., Penry J.K., Dreifuss F.E. Antiepileptic Drugs. 3rd ed:1989;937 Raven Press, New York.
32. Riekkinen P.J., Ylinen A., Halonen T., Sivenius J., Pitkanen A. Cerebrospinal fluid GABA and seizure control with vigabatrin. Br. J. Clin. Pharmacol. 27(S1):1989;87S-94S.
33. Schechter P.J., Tranier Y., Jung M.J., Böhlen P. Audiogenic seizure protection by elevated brain GABA concentration in mice: effects of γ-acetylenic GABA and γ-vinyl GABA, two irreversible GABA-T inhibitors. Eur. J. Pharmacol. 45:1977;319-328.
34. Schousboe A., Larsson O.M., Seiler N. Stereoselective uptake of the GABA-transaminase inhibitors gamma-vinyl GABA and gamma-acetylenic GABA into neurons and astrocytes. Neurochem. Res. 11:1986;1497-1505.
35. Shin C., Rigsbee L.C., McNamara J.O. Anti-seizure and anti-epileptogenic effect of γ-vinyl γ-aminobutyric acid in amygdaloid kindling. Brain Res. 398:1986;370-374.
36. Sihra T.S., Nicholls D.G. 4-Aminobutyrate can be released exocytotically from guinea-pig cerebral cortical synaptosomes. J. Neurochem. 49:1987;261-267.
37. Szerb J.C. Turnover and release of GABA in rat cortical slices: effect of a GABA-T inhibitor, gabaculine. Neurochem. Res. 7:1982;191-204.
38. Thompson S.M., Gähwiler B.H. Activity-dependent disinhibition. I. Repetitive stimulation reduces IPSP driving force and conductance in the hippocampus in vitro. J. Neurophysiol. 61:1989;501-511.
39. Upton N. Mechanisms of action of new antiepileptic drugs: rational design and serendipitous findings. Trends Pharmacol. Sci. 15:1994;456-463.
40. Wilder B.J. Antiepileptic drugs - current use. Can. J. Neurol. Sci. 23:1996;S18-S23.
41. Wood J.D., Kurylo E., Lane R. γ-Aminobutyric acid release from synaptosomes prepared from rats treated with isonicotinic acid hydrazide and gabaculine. J. Neurochem. 50:1988;1839-1843.